Author Archives: Cara

Ovarian Cancer Incidence and Mortality Decreased

New data has been released showing that the number of women who get ovarian cancer has decreased as well as the number of women who die from the disease. Since … Continue reading 

Posted in News | Leave a comment

Federal Funding for Cancer Research in Jeopardy

Due to the current crisis in Washington regarding the budget, appropriations and debt ceiling, federal funding for cancer research is in jeopardy. Due to the sequester, cancer research may take … Continue reading 

Posted in News | Leave a comment

Hormonal Risk & Tumor Aggressiveness

In an analysis of more than 4,000 women with ovarian cancer, it appears that some hormonal and reproductive factors may affect tumor aggressiveness. The study showed that increased age was … Continue reading 

Posted in News | Leave a comment

Phase II Study Shows No Improvement in PFS with Addition of Pertuzumab

A study of 149 women with platinum sensitive ovarian cancer, half treated with carboplatin and paclitaxel or gemcitabine, half with that treatment plus pertuzumab, showed that the addition of pertuzumab … Continue reading 

Posted in News | Leave a comment

Farletuzumab Trial Fails to Show Increase in PFS

A Phase III trial of a potential new treatment for ovarian cancer, farletuzumab, did not know any improvement in progression free survival. See a new article here

Posted in News | Tagged , , , | Leave a comment

Pap Test for Ovarian Cancer?

A small study of 46 women showed that examining cells on the cervix can help identify ovarian and uterine cancers. In this study, DNA analysis detected 41% of ovarian cancer … Continue reading 

Posted in News | Tagged , , , , | Leave a comment

Screening for Familial Ovarian Cancer

More than 3,000 women with a high risk of developing ovarian cancer were enrolled in a screening study. These women were screened every year with a CA-125 blood test and … Continue reading 

Posted in News | Leave a comment

BRCA Mutation Does Not Have Effect on Long Term Survival

A study of 1,626 women with ovarian cancer showed that women with a BRCA mutation had increased survival rates at three years after diagnosis, but had the same rates of … Continue reading 

Posted in News | Leave a comment

Statement on the Passing of Senator Daniel K. Inouye

The Ovarian Cancer National Alliance sends our sympathies to the family of Daniel K. Inouye, senator of Hawaii and a long-time supporter of women with ovarian cancer. Senator Inouye was … Continue reading 

Posted in Blog | Leave a comment

Metformin May Increase Survival For Women With Ovarian Cancer

Metformin, a drug used to treat diabetes and polycystic ovarian syndrome (PCOS), may increase survival for women with ovarian cancer. A study of 239 women with ovarian cancer divided them … Continue reading 

Posted in News | Leave a comment

Study Suggests Screening Useful for High Risk Women

A study of 3,500 women at high risk of developing ovarian/fallopian cancer were screened annually for approximately three years with the CA-125 blood test and transvaginal ultrasound. In this population, … Continue reading 

Posted in News | Tagged , , | Leave a comment

Hospice Reimbursement May Disincentivize Care for Expensive Patients

A study by the Commonwealth Foundation found that patients with expensive treatment, such as palliative chemotherapy, were more likely to be turned away from hospice facilities. Some findings include The … Continue reading 

Posted in News | Tagged , , | Leave a comment